Biofrontera Inc. (NASDAQ:BFRIW – Get Free Report) saw a large decline in short interest in July. As of July 31st, there was short interest totaling 2,578 shares, a decline of 60.0% from the July 15th total of 6,447 shares. Based on an average daily trading volume, of 5,485 shares, the days-to-cover ratio is currently 0.5 days.
Biofrontera Stock Performance
Shares of NASDAQ:BFRIW remained flat at $0.02 during trading on Friday. 30,328 shares of the stock were exchanged, compared to its average volume of 6,234. The business’s fifty day moving average is $0.03 and its two-hundred day moving average is $0.04. Biofrontera has a 12 month low of $0.02 and a 12 month high of $0.15.
About Biofrontera
Biofrontera AG is a biopharmaceutical company headquartered in Leverkusen, Germany, specializing in the development, manufacture and commercialization of dermatology products. Founded in 1997, the company focuses on therapies for skin diseases through innovative drug and device combinations. Its core business centers on photodynamic therapy, where a photosensitizing agent is activated by a specialized light source to treat precancerous and cancerous skin conditions.
The company’s flagship product, Ameluz, is a topical formulation of aminolevulinic acid used in conjunction with the BF-RhodoLED irradiation device.
Featured Stories
- Five stocks we like better than Biofrontera
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
- AirJoule Technologies: Short Squeeze Setup Amid Rising Risks
Receive News & Ratings for Biofrontera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biofrontera and related companies with MarketBeat.com's FREE daily email newsletter.
